-
CVS and Walgreens have begun to take appointments for the new COVID booster during a KP variant-fueled surge. The booster targets omicron subvariant KP.2. Uninsured adults will no longer get free COVID vaccines under the CDC's Bridge Access Program, which ends this month.
-
The FDA recently approved the anti-amyloid drug donanemab, sold as Kisunla. The medication can delay cognitive decline in early Alzheimer's patients by about seven months, but it is expensive and can have serious side effects. Still, it will be soon be available for some patients in South Texas.
-
A virologist and vaccine researcher at Texas Biomedical Research Institute explains the difference between H5N1 and H5N2 and what the fatal human case of H5N2 in Mexico City might mean for humans.
-
'It'll be rough through January, most of February, likely. And then hopefully we'll start to see some relief,' according to Dr. Jason Bowling, an infectious diseases doctor at UT Health San Antonio and University Hospital.
-
San Antonio’s Metropolitan Health District reported 646 new COVID cases in the week ending October 17. That's up slightly from the week before when 616 new cases were reported.
-
The study found boys diagnosed with autism were more than three times as likely to have been born to mothers who reported consuming at least one or more servings of diet soda a day during pregnancy or breastfeeding.
-
The Metropolitan Heath District confirmed more than 2,600 new COVID cases in the week ending Sept. 18.
-
A $46 million award from the National Institutes of Health will help eight San Antonio area institutions move promising scientific research into practice that helps people.
-
One in five of the people who work in San Antonio are employed in healthcare or bioscience.
-
San Antonio researchers have discovered that the COVID virus can use metal ions like magnesium and calcium in your own body as a disguise to hide itself from your immune system.